Literature DB >> 6260679

Virus-specific cytotoxic activity to mammary tumor cells of sera from normal and tumor-bearing mice with inhibition at low dilutions.

P Creemers.   

Abstract

Sera from normal mice and mice bearing murine mammary tumor virus (MTV)-induced tumors showed cytotoxic reactions to the MTV-producing Mm5mt/c1 cell line. The reaction could be blocked by the addition of MTV, but not of purified gp52 and p28. In sera from tumor bearers, cytotoxic responses ranged from 15 to 66%; reactivity was generally highest when the serum was diluted 32 to 128 times. The cytotoxic sera from the normal animals showed a much lower activity; again, there was a lack of cytotoxic response at lower serum dilutions. Low dilutions (1 to 64) of sera from tumor-bearing and normal mice were found to inhibit the MTV-specific cytotoxic activity of rabbit anti-MTV serum on the Mm5mt/c1 cell line. Specificity of this phenomenon was deduced from the fact that there was less inhibition by the mouse sera of anti-Rauscher leukemia virus-specific cytotoxic activity to Rauscher leukemia virus-infected cells and of anti-vaccinia virus serum to vaccinia virus-infected cells. Absorption of the mouse sera with rabbit anti-gp52 serum almost completely abolished the inhibition; after absorption with MTV, inhibition was somewhat reduced. The effect of free gp52 and MTV/anti-MTV immune complexes on the anti-MTV immune response is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260679      PMCID: PMC350579          DOI: 10.1128/iai.32.1.15-23.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  The major polypeptides of the murine-mammary-tumor virus isolated by plant-lectin affinity chromatography.

Authors:  F Westenbrink; W Koornstra; P Bentvelzen
Journal:  Eur J Biochem       Date:  1977-06-01

2.  Immunologic evidence for horizontal transmission of MTV.

Authors:  P B Blair; M A Lane
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

3.  Spontaneous occurrence of precipitating antibodies to the mammary tumor virus in mice.

Authors:  M Müller; C Hageman; J H Daams
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

4.  Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyuridine-stimulated mammary tumor cell cultures.

Authors:  D L Fine; J K Plowman; S P Kelley; L O Arthur; E A Hillman
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

6.  Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.

Authors:  J N Ihle; L O Arthur; D L Fine
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

7.  Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.

Authors:  R L Stolfi; R A Fugmann; L M Stolfi; D S Martin
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

8.  Factors interfering with cellular immunological responses to the murine mammary tumor virus in tumor-bearing mice.

Authors:  P Creemers; J Brinkhof
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

9.  Cellular immunity to the mammary tumour virus in mice bearing primary mammary tumours.

Authors:  P Creemers; P Bentvelzen
Journal:  Eur J Cancer       Date:  1977-06       Impact factor: 9.162

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV).

Authors:  O Stutman
Journal:  Springer Semin Immunopathol       Date:  1982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.